Rich Shea | CEO, Basking Biosciences – RNA Aptamers for Acute Thrombosis Treatment
Update: 2025-09-05
Description
In this episode of Executive Insights for Life Sciences Innovators, we sit down with Rich Shea, CEO of Basking Biosciences, to discuss the company’s pioneering work with RNA aptamer technology for the treatment of acute thrombosis. Rich shares insights on Basking’s scientific journey, the challenges of advancing a novel therapeutic approach, and the opportunities ahead in cardiovascular care.
Learn more at genecoda.com.
Originally recorded and streamed on YouTube Live on February 24, 2025.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
